Precision Medicine And Global Aging Will Open Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
14 Aug 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
US$50.00
84.7% undervalued intrinsic discount21 Aug
US$7.65
1Y
-81.2%7D
3.7%